US OptionsDetailed Quotes
HUMA250117C3500
- 1.40
- -0.15-9.68%
15min DelayClose Dec 23 16:00 ET
1.55High1.30Low
1.55Open1.55Pre Close34 Volume21 Open Interest3.50Strike Price4.53KTurnover159.17%IV5.38%PremiumJan 17, 2025Expiry Date1.15Intrinsic Value100Multiplier25DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.8156Delta0.1379Gamma3.32Leverage Ratio-0.0107Theta0.0016Rho2.71Eff Leverage0.0032Vega
Humacyte Stock Discussion
FDA delay in approving Humacyte stemmed from national security concerns - developed in collaboration with the DoD. An undeniable strategic advantage for the U.S. military.
The fact that we have a +10 billion $ runway is just nice to know.
Fresenius, with its stake and rights in Humacyte, could face a bidding war from Baxter, which seeks to expand its hemodialysis portfolio. Both see Humacyte’s innovative vascular technology as key to dominating the dialysis market.
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits. GREED will make losr and get trapped.
5. Always remember shorts include dark pools.
6. Most importantly, DON’T BLAME ME for your losses. I already give watchlist and stock education. The ball is on you. I give you “watchlist” which means its on watch for me, not an open po...
$Humacyte (HUMA.US)$
My team of analysts had detected PnD signal currently for this stock. Empty it before it dives suddenly down to possibly $2+. I have already pre-amp all my close followers just now before the down trend.
No comment yet